搅拌铸造法制备和表征GNPs和CNTs增强Al 7075基复合材料

This study investigated the effects of adding graphene nanoplates (GNPs) and carbon nanotubes (CNTs) into the Al7075 matrix via the stir casting method on the microstructure and mechanical properties of the fabricated composites. By increasing the volume fraction of reinforcements, the fraction of porosity increased. The X-ray diffraction results showed that the addition of reinforcements into the Al7075 changed the dominant crystal orientation from (002) to (111). Field emission scanning electron microscopy images also showed the distribution of clustered reinforcements in the matrix. Between the two reinforcements, the addition of CNTs generated a lower fraction of porosities. Through the addition of 0.52vol% GNPs into the matrix, the hardness, ultimate tensile strength and uniform elongation increased by 44%, 32%, and 180%, respectively. Meanwhile, the presence of 0.71vol% CNTs in the matrix increased the hardness, tensile strength and uniform elongation by 108%, 129%, and 260%, respectively.     

Global histone modification patterns predict risk of prostate cancer recurrence

Aberrations in post-translational modifications of histones have been shown to occur in cancer cells but only at individual promoters; they have not been related to clinical outcome. Other than being targeted to promoters, modifications of histones, such as acetylation and methylation of lysine and arginine residues, also occur over large regions of chromatin including coding regions and non-promoter sequences, which are referred to as global histone modifications. Here we show that changes in global levels of individual histone modifications are also associated with cancer and that these changes are predictive of clinical outcome. Through immunohistochemical staining of primary prostatectomy tissue samples, we determined the percentage of cells that stained for the histone acetylation and dimethylation of five residues in histones H3 and H4. Grouping of samples with similar patterns of modifications identified two disease subtypes with distinct risks of tumour recurrence in patients with low-grade prostate cancer. These histone modification patterns were predictors of outcome independently of tumour stage, preoperative prostate-specific antigen levels, and capsule invasion. Thus, widespread changes in specific histone modifications indicate previously undescribed molecular heterogeneity in prostate cancer and might underlie the broad range of clinical behaviour in cancer patients.